Patents by Inventor Nima Shiva

Nima Shiva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEMO BINDING DOMAIN FUSION PROTEINS
    Publication number: 20150031598
    Abstract: Novel fusion proteins compromising nuclear factor kB essential modulator-binding (NEMO) domain or a fragment thereof and MCoTI-I/II or a fragment thereof, and their use for the treatment of inflammatory diseases and other medical conditions.
    Type: Application
    Filed: August 22, 2014
    Publication date: January 29, 2015
    Inventors: Nima Shiva, Mark W. Nowak
  • Fluorescent Assays Using Orthogonal tRNA - Aminoacyl Synthetase Pairs
    Publication number: 20090081669
    Abstract: An unnatural amino acid comprising a fluorescent moiety is site-specifically incorporated into a protein through the use of an O-tRNA/O-RS pair which is orthogonal to the tRNAs and aminoacyl synthetases of a translation system, thereby allowing the protein to be analyzed.
    Type: Application
    Filed: February 1, 2007
    Publication date: March 26, 2009
    Applicant: ENCODE BIO, INC.
    Inventors: Nima Shiva, Mark W. Nowak, Niki Zacharias
  • Orthogonal Aminoacyl Synthetase-tRNA Pairs for Incorporating Unnatural Amino Acids Into Proteins
    Publication number: 20070178554
    Abstract: Methods of incorporating unnatural amino acids into proteins in eukaryotic cells using an orthogonal aminoacyl synthetase and an orthogonal tRNA derived from Lactococcus lactis.
    Type: Application
    Filed: February 1, 2007
    Publication date: August 2, 2007
    Inventors: Nima Shiva, Mark Nowak, Niki Zacharias
  • Methods of precise molecular-level determination of ligand-receptor interactions and designing selective drug compounds based on said interactions
    Publication number: 20050009103
    Abstract: The present invention discloses methods of determining highly precise interactions between a membrane protein receptor and various compounds. The methods of the present invention utilize a receptophore model system and nonsense codon suppression methods combined with heterologous in vivo expression in Xenopus oocytes.
    Type: Application
    Filed: July 8, 2004
    Publication date: January 13, 2005
    Applicant: Neurion Pharmaceuticals
    Inventors: Dennis Dougherty, Henry Lester, Nima Shiva